MCL1 and neoplasm: Consistent with the necessity for dual inhibition of functionally redundant pro-survival BH3 family members BCL-2 and MCL-1, combined administration of voruciclib and venetoclax resulted in significantly enhanced tumor growth inhibition compared to either single agent alone, in two distinct xenograft models of ABC DLBCL.